e-learning
resources
Virtual 2021
08.09.2021
Emerging evidence on sub-acute and long COVID-19
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
SARS-CoV-2: Survival in COPD phenotypes
M. Pavitt (Billingshurst (West Sussex), United Kingdom), S. Krivinskas (Billingshurst (West Sussex), United Kingdom), J. Congleton (Billingshurst (West Sussex), United Kingdom), S. Hippolyte (Billingshurst (West Sussex), United Kingdom)
Source:
Virtual Congress 2021 – Emerging evidence on sub-acute and long COVID-19
Session:
Emerging evidence on sub-acute and long COVID-19
Session type:
Oral Presentation
Number:
4195
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Pavitt (Billingshurst (West Sussex), United Kingdom), S. Krivinskas (Billingshurst (West Sussex), United Kingdom), J. Congleton (Billingshurst (West Sussex), United Kingdom), S. Hippolyte (Billingshurst (West Sussex), United Kingdom). SARS-CoV-2: Survival in COPD phenotypes. 4195
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
COPD phenotypes
Source: International Congress 2016 – PG1 Asthma and chronic obstructive pulmonary disease
Year: 2016
COPD phenotypes
Source: International Congress 2015 – PG2 Asthma and COPD
Year: 2015
Stability of COPD phenotypes over time
Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease
Year: 2012
Survival characteristics and predictors of mortality in COPD subjects
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Year: 2019
Identification and analysis of clinical phenotypes in COPD patients: PALOMB Cohort
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021
The distribution of phenotypes in a population of severe COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Survival following pulmonary rehabilitation in COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 209s
Year: 2004
Tree years survival rates of COPD patients that hospitalized for acute excecerbation of COPD
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014
Multicomponent indices to predict survival in COPD: the COCOMICS study
Source: Eur Respir J 2013; 42: 323-332
Year: 2013
Prediction models for exacerbations in different COPD patient populations: Results of five large databases
Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD
Year: 2016
Clinical COPD phenotypes identified by cluster analysis: validation with mortality
Source: Eur Respir J 2012; 40: 495-496
Year: 2012
Metabolic syndrome in COPD patients without cardiovascular comorbidities: Co-existence or a different COPD phenotype?
Source: Annual Congress 2010 - COPD: phenotyping and monitoring
Year: 2010
Frequency of exacerbations in patients with COPD: an analysis of the SPIROMICS cohort
Source: International Congress 2017 – COPD: latest insights into the management of patients
Year: 2017
COPD phenotypes and 5-years mortality risk prediction: PALOMB Cohort
Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Year: 2020
Survival in COPD patients with hospitalization due to exacerbation
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014
Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
COPD Phenotypes and Comorbidities
Source: International Congress 2017 – COPD biomarkers
Year: 2017
Heterogeneity inside group D COPD patients: About 827 cases
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept